Cannabis Therapy Corp. (CTCO) – an Emerging Growth Company

Cannabis Therapy Corp specializes in proprietary identification, extraction, production, and marketing of pharmaceutical-grade cannabinoids and cannabinoid-containing products for the food science, pharmaceutical, nutritional supplement and nutraceutical industries.

Cannabis has been used medicinally for thousands of years to relieve symptoms of pain, nausea, anorexia, muscle stiffness, bladder dysfunction, and to treat a variety of sleep, pain and physiological disorders.

For most of the past century, investment and research in medicinal cannabis and cannabinoids was virtually non-existent due to legal restrictions. With the gradual legalization of medicinal cannabis at the state level (22 states and DC), research into medical and pharmaceutical applications has expanded dramatically.

Cannabis Therapy Corp is positioned to develop and market cannabinoid products and to gain a significant share of the immensely attractive and rapidly growing medicinal CBD and cannabis markets.


Initiating Coverage on Cannabis Therapy Inc. (CTCO)

The Company: Cannabis Therapy Corporation “CTC” aims to become a leader in the research, development and commercialization of biopharmaceutical-grade, non-psychoactive cannabis based medicinal therapies and food supplements made from unregulated low-THC hemp cannabis in both humans and pet animals.